Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 are not candidates
Draw 20 units from the 5mg/ml vial thinking you are getting 0.5mg and you have just given yourself 1mg, double what you intended
Science 362, 181185
/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Week 4 to 8: visible structural changes
Zepbound (tirzepatide) is an FDA-approved dual GIP/GLP-1 receptor agonist indicated for chronic weight management in adults with obesity or overweight with weight-related comorbidities
US$ 22.48
US$ 21.15
US$ 22.84
US$ 21.44
US$ 21.65
US$ 20.98
US$ 21.33
US$ 28.74
